Work on 5G updated following a public consultation
Today, ANSES is publishing an updated version of its expert appraisal on the potential health effects of 5G, following the public consultation on its first opinion, organised between April and June 2021. The further details provided from the analysis of the contributions and the inclusion of recent exposure measurements confirm the expert appraisal's initial findings. Based on current knowledge, the Agency believes it unlikely that the deployment of 5G will lead to new health risks with regard to previous telephone generations.
Encouraging formaldehyde substitution in several occupational sectors
Formaldehyde has been recognised as a carcinogen at European level and must be substituted by other substances or processes to protect the health of exposed workers. ANSES carried out several expert appraisals to identify less hazardous alternatives in five occupational sectors, examining the enabling factors and barriers to substitution in several industries. This work will support the government in enforcing substitution requirements among employers. It should also help those involved in the prevention of occupational health risks to support substitution efforts.
Inhalation of sea spray containing brevetoxins can cause poisoning
Brevetoxins produced by microalgae were first detected in France in 2018. Inhalation of contaminated sea spray during swimming or water sports can cause poisoning. Professionals working in contaminated areas are the most exposed, with pregnant women and people with asthma being the most vulnerable. Although no cases have been reported to date in France, further knowledge is needed.
Drosophila as a model for exploring the effects of pesticides on Parkinson’s disease
The Drosophila melanogaster or fruit fly may be used to assess whether pesticides induce an increased risk of developing Parkinson’s disease. This was the conclusion reached by scientists in the ANSES Lyon Laboratory’s Neurodegenerative Diseases Unit, who have been collaborating with researchers from the École Normale Supérieure in Lyon. Working on paraquat, they also showed that the effects of this compound on proteins were not strictly identical to those of ageing. We interviewed Jean-Noël Arsac, one of the authors of the study.
As part of the French Presidency of the Council of the European Union (FPEU ), ANSES will be organising and taking part in several events involving counterpart agencies and scientific and institutional partners. Discover some of the highlights planned for the first half of 2022, covering a wide range of topics including veterinary medicinal products, food and chemicals.
What does the new European regulation on veterinary medicinal products change?
The new European regulation on veterinary pharmaceuticals came into force on 28 January 2022. The Director of the French Agency for Veterinary Medicinal Products (ANMV), Jean-Pierre Orand, assesses what will change.
Phytotherapy and aromatherapy: adapting risk assessment in veterinary medicine
Herbal preparations (phytotherapy) and essential oils (aromatherapy) are increasingly being used as alternatives to other “allopathic” medicinal products for the treatment of animals. This is true even for food-producing animals. If the products used have a therapeutic purpose, they are considered veterinary medicinal products.This means it should be possible to guarantee there is no risk to consumers of foods derived from treated animals. However, it is complicated to implement the current regulations to assess this risk for herbal medicinal products. ANSES therefore issued an internal request to propose a specific assessment methodology for herbal veterinary medicinal products.
The CNDP and ANSES forge a partnership to better inform and involve the public
As part of their respective commitments at the service of high-quality public debate on environmental issues, the National Commission for Public Debate (CNDP) and the French Agency for Food, Environmental and Occupational Health & Safety (ANSES) are entering into a partnership to improve the information provided to the public and support civic participation.
Human hormonal treatments: be careful not to expose your pets
In dogs and cats, repeated contact with their owner’s topical hormone replacement therapy can cause hormonal problems. Following reports of adverse effects in several European countries, ANSES-ANMV (French Agency for Veterinary Medicinal Products) is inviting owners to apply these medications with the necessary precautions to avoid exposing their pets.